114 related articles for article (PubMed ID: 16408800)
1. [Heparanase: target for cancer metastatic therapy].
Zhao HJ; Zhang XW; Ding J
Yao Xue Xue Bao; 2005 Oct; 40(10):871-5. PubMed ID: 16408800
[No Abstract] [Full Text] [Related]
2. [Research advancement on heparanase in tumor metastasis].
Li ZH; Yang SM
Ai Zheng; 2005 Sep; 24(9):1156-60. PubMed ID: 16159446
[TBL] [Abstract][Full Text] [Related]
3. Mammalian heparanase: involvement in cancer metastasis, angiogenesis and normal development.
Vlodavsky I; Goldshmidt O; Zcharia E; Atzmon R; Rangini-Guatta Z; Elkin M; Peretz T; Friedmann Y
Semin Cancer Biol; 2002 Apr; 12(2):121-9. PubMed ID: 12027584
[TBL] [Abstract][Full Text] [Related]
4. Regulation, function and clinical significance of heparanase in cancer metastasis and angiogenesis.
Ilan N; Elkin M; Vlodavsky I
Int J Biochem Cell Biol; 2006; 38(12):2018-39. PubMed ID: 16901744
[TBL] [Abstract][Full Text] [Related]
5. Molecular properties and involvement of heparanase in cancer metastasis and angiogenesis.
Vlodavsky I; Friedmann Y
J Clin Invest; 2001 Aug; 108(3):341-7. PubMed ID: 11489924
[No Abstract] [Full Text] [Related]
6. Heparanase: one molecule with multiple functions in cancer progression.
Vlodavsky I; Elkin M; Abboud-Jarrous G; Levi-Adam F; Fuks L; Shafat I; Ilan N
Connect Tissue Res; 2008; 49(3):207-10. PubMed ID: 18661344
[TBL] [Abstract][Full Text] [Related]
7. Heparanase, a key target for gene therapy against human malignancies.
Zhang Y; Wang Y; Fu Z; Shen F
ScientificWorldJournal; 2007 Dec; 7():1965-7. PubMed ID: 18167611
[No Abstract] [Full Text] [Related]
8. Heparanase induces vascular endothelial growth factor expression: correlation with p38 phosphorylation levels and Src activation.
Zetser A; Bashenko Y; Edovitsky E; Levy-Adam F; Vlodavsky I; Ilan N
Cancer Res; 2006 Feb; 66(3):1455-63. PubMed ID: 16452201
[TBL] [Abstract][Full Text] [Related]
9. Downregulating the expression of heparanase inhibits the invasion, angiogenesis and metastasis of human hepatocellular carcinoma.
Zhang Y; Li L; Wang Y; Zhang J; Wei G; Sun Y; Shen F
Biochem Biophys Res Commun; 2007 Jun; 358(1):124-9. PubMed ID: 17467664
[TBL] [Abstract][Full Text] [Related]
10. Oligomannurarate sulfate, a novel heparanase inhibitor simultaneously targeting basic fibroblast growth factor, combats tumor angiogenesis and metastasis.
Zhao H; Liu H; Chen Y; Xin X; Li J; Hou Y; Zhang Z; Zhang X; Xie C; Geng M; Ding J
Cancer Res; 2006 Sep; 66(17):8779-87. PubMed ID: 16951194
[TBL] [Abstract][Full Text] [Related]
11. Heparanase, tissue factor, and cancer.
Nadir Y; Vlodavsky I; Brenner B
Semin Thromb Hemost; 2008 Mar; 34(2):187-94. PubMed ID: 18645924
[TBL] [Abstract][Full Text] [Related]
12. Mechanism of anti-angiogenic activities of chitooligosaccharides may be through inhibiting heparanase activity.
Quan H; Zhu F; Han X; Xu Z; Zhao Y; Miao Z
Med Hypotheses; 2009 Aug; 73(2):205-6. PubMed ID: 19342181
[TBL] [Abstract][Full Text] [Related]
13. Silencing of heparanase by siRNA inhibits tumor metastasis and angiogenesis of human breast cancer in vitro and in vivo.
Zhang ZH; Chen Y; Zhao HJ; Xie CY; Ding J; Hou YT
Cancer Biol Ther; 2007 Apr; 6(4):587-95. PubMed ID: 17457040
[TBL] [Abstract][Full Text] [Related]
14. Heparanase coagulation and cancer progression.
Nadir Y; Brenner B
Best Pract Res Clin Haematol; 2009 Mar; 22(1):85-92. PubMed ID: 19285275
[TBL] [Abstract][Full Text] [Related]
15. Heparanase, heparin and the coagulation system in cancer progression.
Vlodavsky I; Ilan N; Nadir Y; Brenner B; Katz BZ; Naggi A; Torri G; Casu B; Sasisekharan R
Thromb Res; 2007; 120 Suppl 2():S112-20. PubMed ID: 18023704
[TBL] [Abstract][Full Text] [Related]
16. Expression of heparanase in renal cell carcinomas: implications for tumor invasion and prognosis.
Mikami S; Oya M; Shimoda M; Mizuno R; Ishida M; Kosaka T; Mukai M; Nakajima M; Okada Y
Clin Cancer Res; 2008 Oct; 14(19):6055-61. PubMed ID: 18809970
[TBL] [Abstract][Full Text] [Related]
17. Function of heparanase in prostate tumorigenesis: potential for therapy.
Lerner I; Baraz L; Pikarsky E; Meirovitz A; Edovitsky E; Peretz T; Vlodavsky I; Elkin M
Clin Cancer Res; 2008 Feb; 14(3):668-76. PubMed ID: 18212251
[TBL] [Abstract][Full Text] [Related]
18. The development of inhibitors of heparanase, a key enzyme involved in tumour metastasis, angiogenesis and inflammation.
Ferro V; Hammond E; Fairweather JK
Mini Rev Med Chem; 2004 Aug; 4(6):693-702. PubMed ID: 15279603
[TBL] [Abstract][Full Text] [Related]
19. Involvement of heparanase in tumor metastases: a new target in cancer therapy?
Boyd DD; Nakajima M
J Natl Cancer Inst; 2004 Aug; 96(16):1194-5. PubMed ID: 15316047
[No Abstract] [Full Text] [Related]
20. Heparanase expression correlates with metastatic capability in human choriocarcinoma.
Jingting C; Yangde Z; Yi Z; Huining L; Rong Y; Yu Z
Gynecol Oncol; 2007 Oct; 107(1):22-9. PubMed ID: 17688924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
